Skip to main content
SURMODICS INC logo

SURMODICS INC — Investor Relations & Filings

Ticker · SRDX ISIN · US8688731004 LEI · 549300H76KXCAAGUS878 US Manufacturing
Filings indexed 1,062 across all filing types
Latest filing 2011-01-05 Director's Dealing
Country US United States of America
Listing US SRDX

About SURMODICS INC

https://www.surmodics.com/

Surmodics, Inc. provides performance-enhancing technologies for the healthcare industry, focusing on medical devices and in vitro diagnostics. The company is a leading provider of surface modification technologies, offering customized hydrophilic, hemocompatible, and drug-delivery coatings for intravascular medical devices. In addition to its coatings business, Surmodics develops and commercializes a portfolio of vascular intervention medical devices for the treatment of peripheral arterial and venous disease, including thrombectomy and radial access platforms. The company also offers end-to-end contract development and manufacturing services. Its In Vitro Diagnostics (IVD) division supplies critical chemical components for immunoassays and microarrays, aiming to enhance the sensitivity and reproducibility of diagnostic tests.

Recent filings

Filing Released Lang Actions
Director's Dealing 2011
Director's Dealing
2011-01-05 English
Regulatory Filings 2010
Regulatory Filings
2010-12-30 English
FORM 3 SUBMISSION
Director's Dealing
2010-12-29 English
4 Filing
Director's Dealing
2010-12-29 English
PRE 14A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14A Proxy Statement filed with the SEC, as indicated by the header and references to Rule 14a-101 and Section 14(a) of the Securities Exchange Act of 1934. It includes detailed information about the Annual Meeting of Shareholders, including election of directors, voting procedures, executive compensation advisory votes, and other shareholder meeting matters. The document is not a full annual report or financial statement but rather the proxy solicitation materials for the annual meeting. This matches the definition of Proxy Solicitation & Information Statement (PSI). The document length is substantial (15,000 characters), and it contains detailed proxy information, not just an announcement or a brief notice, so it is not an RPA or RNS. Therefore, the correct classification is PSI with high confidence.
2010-12-23 English
Regulatory Filings 2010
Regulatory Filings
2010-12-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.